Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Shields

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Clinical Lung Cancer|February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not ChemoimmunotherapyYizhen Guo, Lai Wei, Sandip H Patel, et al.
Nature Communications|May 4, 2017
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2Sigurdis Haraldsdottir, Thorunn Rafnar, Wendy L Frankel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAngel Qin, Songzhu Zhao, Abdul Miah, et al.
Nature Communications|July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapyGina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2016
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Roy S Herbst, Douglas Arenberg, et al.
Cancer Medicine|July 28, 2025
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based TherapiesMingjia Li, Po-Lan Su, Songzhu Zhao, et al.
Journal of the National Cancer Institute|January 5, 2006
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsLois B Travis, Charles S Rabkin, Linda Morris Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Laura Bierut, Douglas Arenberg, et al.
JCI Insight|February 7, 2023
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapyJoseph H Azar, John P Evans, Madison H Sikorski, et al.
JCO Precision Oncology|July 12, 2021
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention InitiativeRachel Pearlman, Wendy L Frankel, Benjamin J Swanson, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Clinical Lung Cancer|February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not ChemoimmunotherapyYizhen Guo, Lai Wei, Sandip H Patel, et al.
Nature Communications|May 4, 2017
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2Sigurdis Haraldsdottir, Thorunn Rafnar, Wendy L Frankel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAngel Qin, Songzhu Zhao, Abdul Miah, et al.
Nature Communications|July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapyGina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2016
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Roy S Herbst, Douglas Arenberg, et al.
Cancer Medicine|July 28, 2025
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based TherapiesMingjia Li, Po-Lan Su, Songzhu Zhao, et al.
Journal of the National Cancer Institute|January 5, 2006
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsLois B Travis, Charles S Rabkin, Linda Morris Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Laura Bierut, Douglas Arenberg, et al.
JCI Insight|February 7, 2023
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapyJoseph H Azar, John P Evans, Madison H Sikorski, et al.
JCO Precision Oncology|July 12, 2021
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention InitiativeRachel Pearlman, Wendy L Frankel, Benjamin J Swanson, et al.
Pageof 22